Molecular genetic gene-environment studies using candidate genes in schizophrenia: A systematic review

Schizophrenia Research

Volumn 150, Issue 2-3, 2013, Pages 356-365

  Modinos, Gemma ^a   Iyegbe, Conrad ^a   Prata, Diana ^a   Rivera, Margarita ^a,b   Kempton, Matthew J ^a   Valmaggia, Lucia R ^a   Sham, Pak C ^c   van Os, Jim ^d   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Environment; Gene environment interaction; Genetics; Psychosis; Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR; CANNABIS; CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; HLA A24 ANTIGEN; HLA DR1 ANTIGEN; METHIONINE; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE B; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; VALINE;

5 HTTLPR GENE; AKT1 GENE; ALLELE; BDNF GENE; CHILD ABUSE; CNR1 GENE; COMT GENE; DRD4 GENE; ENVIRONMENTAL FACTOR; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HLA A24 GENE; HLA A26 GENE; HLA DR1 GENE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENTAL STRESS; MTHFR GENE; NRG1 GENE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SEASONAL VARIATION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TPH GENE;

ENVIRONMENT; GENE-ENVIRONMENT INTERACTION; GENETICS; PSYCHOSIS; SCHIZOPHRENIA;

ENVIRONMENT; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; SCHIZOPHRENIA;

EID: 84886295886     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.09.010     Document Type: Review

References (76)

1. Alemany S., Arias B., Aguilera M., Villa H., Moya J., Ibanez M.I., Vossen H., Gasto C., Ortet G., Fananas L. Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. Br. J. Psychiatry 2011, 199(1):38-42.
2. Bembenek A., Kociuba L. Seasonality of birth in schizophrenia patients in Poland. Schizophr. Res. 2005, 75(2-3):447-448.
3. Bhattacharyya S., Atakan Z., Martin-Santos R., Crippa J.A., Kambeitz J., Prata D., Williams S., Brammer M., Collier D.A., McGuire P.K. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function. Mol. Psychiatry 2012, 17(12):1152-1155.
4. Bickeboller H., Houwing-Duistermaat J.J., Wang X., Yan X. Dealing with high dimensionality for the identification of common and rare variants as main effects and for gene-environment interaction. Genet. Epidemiol. 2011, 35(Suppl. 1):S35-S40.
5. Boks M.P., Schipper M., Schubart C.D., Sommer I.E., Kahn R.S., Ophoff R.A. Investigating gene environment interaction in complex diseases: increasing power by selective sampling for environmental exposure. Int. J. Epidemiol. 2007, 36(6):1363-1369.
6. Cannon M., Jones P.B., Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 2002, 159(7):1080-1092.
7. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 2006, 7(7):583-590.
8. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57(10):1117-1127.
9. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 2010, 167(5):509-527.
10. Chotai J., Serretti A., Lattuada E., Lorenzi C., Lilli R. Gene-environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms. Psychiatry Res. 2003, 119(1-2):99-111.
11. Collip D., van Winkel R., Peerbooms O., Lataster T., Thewissen V., Lardinois M., Drukker M., Rutten B.P., Van Os J., Myin-Germeys I. COMT Val158Met-stress interaction in psychosis: role of background psychosis risk. CNS Neurosci. Ther. 2011, 17(6):612-619.
12. Darroch J. Biologic synergism and parallelism. Am. J. Epidemiol. 1997, 145(7):661-668.
13. Davies G., Welham J., Chant D., Torrey E.F., McGrath J. A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr. Bull. 2003, 29(3):587-593.
14. Decoster J., van Os J., Myin-Germeys I., De Hert M., van Winkel R. Genetic Variation Underlying Psychosis-inducing Effects of Cannabis: critical Review and Future Directions. Curr. Pharm. Des. 2012, 18(32):5015-5023.
15. Di Forti M., Iyegbe C., Sallis H., Kolliakou A., Falcone M.A., Paparelli A., Sirianni M., La Cascia C., Stilo S.A., Marques T.R., Handley R., Mondelli V., Dazzan P., Pariante C., David A.S., Morgan C., Powell J., Murray R.M. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol. Psychiatry 2012, 72(10):811-816.
16. Duncan L.E., Keller M.C. A critical review of the first 10years of candidate gene-by-environment interaction research in psychiatry. Am. J. Psychiatry 2011, 168(10):1041-1049.
17. Engelman C.D., Baurley J.W., Chiu Y.F., Joubert B.R., Lewinger J.P., Maenner M.J., Murcray C.E., Shi G., Gauderman W.J. Detecting gene-environment interactions in genome-wide association data. Genet. Epidemiol. 2009, 33(Suppl. 1):S68-S73.
18. European Network of Schizophrenia Networks for the Study of Gene-Environment Interactions Schizophrenia aetiology: do gene-environment interactions hold the key?. Schizophr. Res. 2008, 102(1-3):21-26.
19. Fearon R.M., Van Ijzendoorn M.H., Fonagy P., Bakermans-Kranenburg M.J., Schuengel C., Bokhorst C.L. In search of shared and nonshared environmental factors in security of attachment: a behavior-genetic study of the association between sensitivity and attachment security. Dev. Psychol. 2006, 42(6):1026-1040.
20. Geddes J.R., Verdoux H., Takei N., Lawrie S.M., Bovet P., Eagles J.M., Heun R., McCreadie R.G., McNeil T.F., O'Callaghan E., Stober G., Willinger U., Murray R.M. Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr. Bull. 1999, 25(3):413-423.
21. Genetic Risk Outcome in Psychosis Investigators Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch. Gen. Psychiatry 2011, 68(2):138-147.
22. Guerin J.S., Murray D.W., McGrath M.M., Yuille M.A., McPartlin J.M., Doran P.P. Molecular Medicine Ireland guidelines for standardized biobanking. Biopreserv. Biobank. 2010, 8(1):3-63.
23. Hamza T.H., Chen H., Hill-Burns E.M., Rhodes S.L., Montimurro J., Kay D.M., Tenesa A., Kusel V.I., Sheehan P., Eaaswarkhanth M., Yearout D., Samii A., Roberts J.W., Agarwal P., Bordelon Y., Park Y., Wang L., Gao J., Vance J.M., Kendler K.S., Bacanu S.A., Scott W.K., Ritz B., Nutt J., Factor S.A., Zabetian C.P., Payami H. Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet. 2011, 7(8):e1002237.
24. Harris J.R., Burton P., Knoppers B.M., Lindpaintner K., Bledsoe M., Brookes A.J., Budin-Ljosne I., Chisholm R., Cox D., Deschenes M., Fortier I., Hainaut P., Hewitt R., Kaye J., Litton J.E., Metspalu A., Ollier B., Palmer L.J., Palotie A., Pasterk M., Perola M., Riegman P.H., van Ommen G.J., Yuille M., Zatloukal K. Toward a roadmap in global biobanking for health. Eur. J. Hum. Genet. 2012, 20(11):1105-1111.
25. Henquet C., Rosa A., Krabbendam L., Papiol S., Fananas L., Drukker M., Ramaekers J.G., van Os J. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006, 31(12):2748-2757.
26. Henquet C., Rosa A., Delespaul P., Papiol S., Fananas L., van Os J., Myin-Germeys I. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr. Scand. 2009, 119(2):156-160.
27. Insel T.R. Rethinking schizophrenia. Nature 2010, 468(7321):187-193.
28. International Schizophrenia Consortium Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455(7210):237-241.
29. Iyegbe C., Modinos G., Rivera M. Old obstacles on new horizons: the challenge of implementing gene×environment discoveries in schizophrenia research. Public Health-Methodology, Environmental and Systems Issues 2012, 77-106. Intech Publishing.
30. Kantrowitz J.T., Nolan K.A., Sen S., Simen A.A., Lachman H.M., Bowers M.B. Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians. Psychiatr. Q. 2009, 80(4):213-218.
31. Kendler K.S., Gardner C.O. Interpretation of interactions: guide for the perplexed. Br. J. Psychiatry 2010, 197(3):170-171.
32. Keri S., Kiss I., Seres I., Kelemen O. A polymorphism of the neuregulin 1 gene (SNP8NRG243177/rs6994992) affects reactivity to expressed emotion in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(3):418-420.
33. Khoury M.J., Wacholder S. Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies-challenges and opportunities. Am. J. Epidemiol. 2009, 169(2):227-230. (discussion 234-225).
34. Knol M.J., van der Tweel I., Grobbee D.E., Numans M.E., Geerlings M.I. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int. J. Epidemiol. 2007, 36(5):1111-1118.
35. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
36. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., Hirschhorn J.N. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 2008, 9(5):356-369.
37. Mino Y., Oshima I. Seasonality of birth in patients with schizophrenia in Japan. Psychiatry Clin. Neurosci. 2006, 60(2):249-252.
38. Mittal V.A., Ellman L.M., Cannon T.D. Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr. Bull. 2008, 34(6):1083-1094.
39. Moffitt T.E. The new look of behavioral genetics in developmental psychopathology: gene-environment interplay in antisocial behaviors. Psychol. Bull. 2005, 131(4):533-554.
40. Muntjewerff J.W., Ophoff R.A., Buizer-Voskamp J.E., Strengman E., den Heijer M., Consortium G. Effects of season of birth and a common MTHFR gene variant on the risk of schizophrenia. Eur. Neuropsychopharmacol. 2011, 21(4):300-305.
41. Narita K., Sasaki T., Akaho R., Okazaki Y., Kusumi I., Kato T., Hashimoto O., Fukuda R., Koyama T., Matsuo K., Okabe Y., Nanko S., Hohjoh H., Tokunaga K. Human leukocyte antigen and season of birth in Japanese patients with schizophrenia. Am. J. Psychiatry 2000, 157(7):1173-1175.
42. Nicodemus K.K., Marenco S., Batten A.J., Vakkalanka R., Egan M.F., Straub R.E., Weinberger D.R. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol. Psychiatry 2008, 13(9):873-877.
43. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R., Molecular Genetics of Schizophrenia, C. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40(9):1053-1055.
44. Peerbooms O., Rutten B.P., Collip D., Lardinois M., Lataster T., Thewissen V., Rad S.M., Drukker M., Kenis G., van Os J., Myin-Germeys I., van Winkel R. Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress. Acta Psychiatr. Scand. 2012, 125(3):247-256.
45. Psychiatric GWAS Consortium Steering Committee A framework for interpreting genome-wide association studies of psychiatric disorders. Mol. Psychiatry 2009, 14(1):10-17.
46. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Haan L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
47. Robins L.N., Wing J., Wittchen H.U., Helzer J.E., Babor T.F., Burke J., Farmer A., Jablenski A., Pickens R., Regier D.A., et al. The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry 1988, 45(12):1069-1077.
48. Rodgers A., Ezzati M., Vander Hoorn S., Lopez A.D., Lin R.B., Murray C.J., Comparative Risk Assessment Collaborating G. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med. 2004, 1(1):e27.
49. Schafer I., Fisher H.L. Childhood trauma and psychosis-what is the evidence?. Dialogues Clin. Neurosci. 2011, 13(3):360-365.
50. Selten J.P., Cantor-Graae E. Social defeat: risk factor for schizophrenia?. Br. J. Psychiatry 2005, 187:101-102.
51. Selten J.P., Cantor-Graae E. Hypothesis: social defeat is a risk factor for schizophrenia?. Br. J. Psychiatry Suppl. 2007, 51:s9-s12.
52. Selten J.P., van der Ven E., Rutten B.P.F., Cantor-Graae E. The social defeat hypothesis of schizophrenia: an update. Schizophr. Bull. 2013, (first published online September 23. 2013). http://dx.doi.org/10.1093/schbul/sbt134.
53. Simons C.J., Wichers M., Derom C., Thiery E., Myin-Germeys I., Krabbendam L., van Os J. Subtle gene-environment interactions driving paranoia in daily life. Genes Brain. Behav. 2009, 8(1):5-12.
54. Stefanis N.C., Henquet C., Avramopoulos D., Smyrnis N., Evdokimidis I., Myin-Germeys I., Stefanis C.N., Van Os J. COMT Val158Met moderation of stress-induced psychosis. Psychol. Med. 2007, 37(11):1651-1656.
55. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Moller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Muhleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Group, Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nothen M.M., Peltonen L., Collier D.A., St Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455(7210):232-236.
56. Stewart R., Soremekun M., Perera G., Broadbent M., Callard F., Denis M., Hotopf M., Thornicroft G., Lovestone S. The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry 2009, 9:51.
57. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60(12):1187-1192.
58. Thomas D. Gene-environment-wide association studies: emerging approaches. Nature reviews. Genetics 2010, 11(4):259-272.
59. Tochigi M., Ohashi J., Umekage T., Kohda K., Hibino H., Otowa T., Marui T., Masui K., Sugahara Y., Kanamori R., Juji T., Kato N., Tokunaga K., Sasaki T. Human leukocyte antigen-a specificities and its relation with season of birth in Japanese patients with schizophrenia. Neurosci. Lett. 2002, 329(2):201-204.
60. Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 1997, 28(1):1-38.
61. Uher R., McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol. Psychiatry 2008, 13(2):131-146.
62. van Os J., Sham P. Gene-environment interactions. The Epidemiology of Schizophrenia 2003, 235-254. Cambridge University Press, Cambridge, England. R.M. Murray, P.B. Jones, E. Susser, J. van Os, M. Cannon (Eds.).
63. van Os J., Rutten B.P., Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr. Bull. 2008, 34(6):1066-1082.
64. van Os J., Kenis G., Rutten B.P. The environment and schizophrenia. Nature 2010, 468(7321):203-212.
65. van Winkel R., Genetic Risk Outcome Psychosis Group Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis sibling analysis and proband follow-up. Arch. Gen. Psychiatry 2011, 68(2):148-157.
66. van Winkel R., Henquet C., Rosa A., Papiol S., Fananas L., De Hert M., Peuskens J., van Os J., Myin-Germeys I. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(1):10-17.
67. van Winkel R., Stefanis N.C., Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull. 2008, 34(6):1095-1105.
68. VanderWeele T.J., Hernandez-Diaz S., Hernan M.A. Case-only gene-environment interaction studies: when does association imply mechanistic interaction?. Genet. Epidemiol. 2010, 34(4):327-334.
69. Wong M.Y., Day N.E., Luan J.A., Wareham N.J. Estimation of magnitude in gene-environment interactions in the presence of measurement error. Stat. Med. 2004, 23(6):987-998.
70. Xu B., Ionita-Laza J., Roos J.L., Boone B., Woodrick S., Sun Y., Levy S., Gogos J.A., Karayiorgou M. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 2012, 44(12):1365-1369.
71. Yuille M., Illig T., Hveem K., Schmitz G., Hansen J., Neumaier M., Tybring G., Wichmann E., Ollier B. Laboratory management of samples in biobanks: European Consensus Expert Group report. Biopreserv. Biobank. 2010, 8(1):65-69.
72. Zammit S., Spurlock G., Williams H., Norton N., Williams N., O'Donovan M.C., Owen M.J. Genotype effects of CHRNA7, CNRI and COMT in schizophrenia: interactions with tobacco and cannabis use. Br. J. Psychiatry 2007, 191:402-407.
73. Zammit S., Lewis G., Dalman C., Allebeck P. Examining interactions between risk factors for psychosis. Br. J. Psychiatry 2010, 197(3):207-211.
74. Zammit S., Owen M.J., Lewis G. Misconceptions about gene-environment interactions in psychiatry. Evid.-Based Ment. Health 2010, 13(3):65-68.
75. Zammit S., Owen M.J., Evans J., Heron J., Lewis G. Cannabis, COMT and psychotic experiences. Br. J. Psychiatry 2011, 199(5):380-385.
76. Zuk O., Hechter E., Sunyaev S.R., Lander E.S. The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(4):1193-1198.